Surveillance of device-associated hospital-acquired infections(DA-HAI)in ICUs plays a vitalrole in hospitalinfection control&quality assurance and
in understanding the changing trend and implementation ofthe antibiotic stewardship program.There islimited data on DA-HAIreported from Indian
ICUs. The single-center study aimed to assess the burden, microbiologic prole, and the trend of DA-HAIs over ve years based on active monthly
surveillance data as a part of Infection control practices in a tertiary care hospital in South India. DA-HAI rates of ventilator-associated pneumonia
(VAP), central line-associated bloodstream infection (CLABSI), and catheter-associated urinary tract infection (CAUTI) per 1,000 device-days were
calculated by dividing the total number of DA-HAIs by the total number ofspecic device-days and multiplying the result by 1,000. Overall DA-HAI
rate of 1.46 per 1000 device days of whichCLABSI andVAP andCAUTI constituted 2.19, 2.09, and 0.42 per 1000 device days,respectively. Diabetes
was the most common comorbidity associated with DA-HAI. In contrast to data from West gram negative organisms constituted the majority of
etiological agentsin DA-HAIsregardless of the duration in ourstudy (82.45%), while gram positive organisms and fungi constituted only 17.54% &
0.87%, respectively. Notably, 96.15% of Acinetobacter baumannii isolates in VAP were carbapenem resistant (CR), while 54.54% Klebsiella
pneumoniae wereCR. InCLABSI 75% of Enterococcusisolates were vancomycin resistant (VRE). InCAUTI 20% of gram negative organisms were
CRandallEnterococcusfaeciumisolatesinwereVRE.TherewasincreasingtrendofCRgramnegativeorganisms causingDA-HAI.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.